Australia is working towards eliminating hepatitis C as a public health threat by 2030. This elimination goal is in line with global targets set by the World Health Organization and targets included in Australia’s National Hepatitis C Strategy 2018–2022.
Prepared by Burnet Institute and the Kirby Institute, this report brings together national data sources to assess Australia’s progress towards eliminating hepatitis C.
Key findings
- Between March 2016 and December 2022, an estimated 100,684 people living with hepatitis C initiated treatment.
- Treatment rates are declining, in 2016, 33,202 people were treated compared to just 5,205 people in 2022.
- An estimated 74,400 Australians remained living with hepatitis C at the end of 2022.
